Boussiotis VA - Search Results

1

IL-1β-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells.

Li L, Kim J, Boussiotis VA. Li L, et al. Among authors: boussiotis va. J Immunol. 2010 Oct 1;185(7):4148-53. doi: 10.4049/jimmunol.1001536. Epub 2010 Sep 3. J Immunol. 2010. PMID: 20817874 Free PMC article.

2

Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.

Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM. Boussiotis VA, et al. J Immunol. 1997 Oct 1;159(7):3156-67. J Immunol. 1997. PMID: 9317113

3

The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor.

Freeman GJ, Cardoso AA, Boussiotis VA, Anumanthan A, Groves RW, Kupper TS, Clark EA, Nadler LM. Freeman GJ, et al. Among authors: boussiotis va. J Immunol. 1998 Sep 15;161(6):2708-15. J Immunol. 1998. PMID: 9743327

4

CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.

Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA. Appleman LJ, et al. Among authors: boussiotis va. J Immunol. 2000 Jan 1;164(1):144-51. doi: 10.4049/jimmunol.164.1.144. J Immunol. 2000. PMID: 10605005

5

IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.

Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE. Boussiotis VA, et al. J Clin Invest. 2000 May;105(9):1317-25. doi: 10.1172/JCI9918. J Clin Invest. 2000. PMID: 10792007 Free PMC article.

6

Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.

McAdam AJ, Chang TT, Lumelsky AE, Greenfield EA, Boussiotis VA, Duke-Cohan JS, Chernova T, Malenkovich N, Jabs C, Kuchroo VK, Ling V, Collins M, Sharpe AH, Freeman GJ. McAdam AJ, et al. Among authors: boussiotis va. J Immunol. 2000 Nov 1;165(9):5035-40. doi: 10.4049/jimmunol.165.9.5035. J Immunol. 2000. PMID: 11046032

7

CTLA-4 regulates cell cycle progression during a primary immune response.

Greenwald RJ, Oosterwegel MA, van der Woude D, Kubal A, Mandelbrot DA, Boussiotis VA, Sharpe AH. Greenwald RJ, et al. Among authors: boussiotis va. Eur J Immunol. 2002 Feb;32(2):366-73. doi: 10.1002/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5. Eur J Immunol. 2002. PMID: 11807776 Free article.

8

CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.

Appleman LJ, van Puijenbroek AA, Shu KM, Nadler LM, Boussiotis VA. Appleman LJ, et al. Among authors: boussiotis va. J Immunol. 2002 Mar 15;168(6):2729-36. doi: 10.4049/jimmunol.168.6.2729. J Immunol. 2002. PMID: 11884439

9

Differential localization and function of ADP-ribosylation factor-6 in anergic human T cells: a potential marker for their identification.

Tzachanis D, Appleman LJ, Van Puijenbroek AA, Berezovskaya A, Nadler LM, Boussiotis VA. Tzachanis D, et al. Among authors: boussiotis va. J Immunol. 2003 Aug 15;171(4):1691-6. doi: 10.4049/jimmunol.171.4.1691. J Immunol. 2003. PMID: 12902467

10

Intrinsic and extrinsic regulation of T lymphocyte quiescence.

Tzachanis D, Lafuente EM, Li L, Boussiotis VA. Tzachanis D, et al. Among authors: boussiotis va. Leuk Lymphoma. 2004 Oct;45(10):1959-67. doi: 10.1080/1042819042000219494. Leuk Lymphoma. 2004. PMID: 15370239 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters